EDMONTON, Nov. 14, 2016 /CNW/ - ZCL Composites Inc. (TSX: ZCL) On October 14, 2016, ZCL announced that Ron Bachmeier, President & CEO of ZCL, was granted a temporary 30-day medical leave of absence to undertake exploratory tests and address treatment options for a diagnosed benign tumour. Mr. Bachmeier's treatment is still ongoing, however he will return to work on a phased basis the week of November 14. The expectation, dependent on satisfactory progress, is for him to resume his full time duties on January 3, 2017. Out of respect for Mr. Bachmeier's privacy, no further details will be provided at this time. Advisory Regarding Forward-Looking Statements This document contains forward-looking statements concerning future events, including the expectations in connection with the phased return to work being planned by the Company's President and CEO. Forward-looking statements are often, but not always, identified by the use of words such as "seek," "anticipate," "plan," "continue," "estimate," "expect," "may," "will," "project," "predict," "potential," "targeting," "intend," "could," "might," "should," "believe" and similar expressions. Actual events or results may differ materially from those reflected in the Company's forward-looking statements due to a number of known and unknown risks, uncertainties and other factors affecting the Company's business and the industries the Company serves generally. The Company believes that the expectations reflected in the forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this report should not be unduly relied upon. The forward-looking statements in this report speak only as of the date of this press release. The Company does not undertake to update any forward-looking statement, whether written or oral, that may be made from time to time by the Company or on the Company's behalf, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws. The forward-looking statements contained in this document are expressly qualified by this cautionary statement.